CS207646B2 - Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid - Google Patents

Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid Download PDF

Info

Publication number
CS207646B2
CS207646B2 CS785183A CS518378A CS207646B2 CS 207646 B2 CS207646 B2 CS 207646B2 CS 785183 A CS785183 A CS 785183A CS 518378 A CS518378 A CS 518378A CS 207646 B2 CS207646 B2 CS 207646B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
sodium salt
formula
sodium
ethanol
Prior art date
Application number
CS785183A
Other languages
Czech (cs)
English (en)
Inventor
Gaston Amiard
Dieter Bormann
Walter Duerckheimer
Jean Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS207646(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Priority to CS794439A priority Critical patent/CS207647B2/cs
Publication of CS207646B2 publication Critical patent/CS207646B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS785183A 1977-08-17 1978-08-08 Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid CS207646B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS794439A CS207647B2 (en) 1977-08-17 1979-06-27 Method of making the crystallic hydrated form of the sodium salt of the oximin derivative of the 7-aminothiazolylacetamidocephalosporan acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (1)

Publication Number Publication Date
CS207646B2 true CS207646B2 (en) 1981-08-31

Family

ID=9194564

Family Applications (2)

Application Number Title Priority Date Filing Date
CS785183A CS207646B2 (en) 1977-08-17 1978-08-08 Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid
CS794439A CS207647B2 (en) 1977-08-17 1979-06-27 Method of making the crystallic hydrated form of the sodium salt of the oximin derivative of the 7-aminothiazolylacetamidocephalosporan acid

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS794439A CS207647B2 (en) 1977-08-17 1979-06-27 Method of making the crystallic hydrated form of the sodium salt of the oximin derivative of the 7-aminothiazolylacetamidocephalosporan acid

Country Status (34)

Country Link
US (1) US4224371A (da)
EP (1) EP0001024B1 (da)
JP (1) JPS5441890A (da)
AT (2) AT366049B (da)
AU (1) AU520898B2 (da)
BG (2) BG33887A3 (da)
CA (1) CA1121343A (da)
CS (2) CS207646B2 (da)
DD (1) DD137588A5 (da)
DE (1) DE2860358D1 (da)
DK (2) DK152213C (da)
EG (1) EG13520A (da)
ES (1) ES472381A1 (da)
FI (1) FI65433C (da)
FR (1) FR2400519A1 (da)
GE (2) GEP19960476B (da)
GR (1) GR73661B (da)
HR (1) HRP931395B1 (da)
HU (1) HU181497B (da)
IE (1) IE47230B1 (da)
IL (1) IL55186A (da)
IT (1) IT1107961B (da)
MD (2) MD247C2 (da)
MX (2) MX155976A (da)
NO (1) NO156168C (da)
NZ (1) NZ188163A (da)
OA (1) OA06016A (da)
PL (1) PL126619B1 (da)
PT (1) PT68431A (da)
RO (1) RO79999A (da)
SI (1) SI7811917A8 (da)
SU (2) SU799666A3 (da)
YU (1) YU42166B (da)
ZA (1) ZA784187B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
WO1987001117A2 (en) * 1985-08-12 1987-02-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (fr) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Procede permettant de remplacer des solvants contenus dans des cristaux de type clathrates
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
PL126619B1 (en) 1983-08-31
BG33888A3 (en) 1983-05-16
NO782782L (no) 1979-02-20
OA06016A (fr) 1981-06-30
ATA52280A (de) 1981-07-15
FR2400519B1 (da) 1980-05-16
AT366050B (de) 1982-03-10
SU799666A3 (ru) 1981-01-23
EP0001024A1 (fr) 1979-03-07
ATA563578A (de) 1981-07-15
JPS6145626B2 (da) 1986-10-08
FI782494A (fi) 1979-02-18
MX5448E (es) 1983-08-09
IL55186A0 (en) 1978-09-29
DK152213B (da) 1988-02-08
IL55186A (en) 1981-07-31
SU852175A3 (ru) 1981-07-30
DK361078A (da) 1979-02-18
MD225C2 (ro) 1995-12-31
CA1121343A (fr) 1982-04-06
MD225B1 (ro) 1995-06-30
CS207647B2 (en) 1981-08-31
YU191778A (en) 1983-02-28
US4224371A (en) 1980-09-23
HU181497B (en) 1983-07-28
GEP19960475B (en) 1996-07-22
FR2400519A1 (fr) 1979-03-16
EG13520A (en) 1982-03-31
GR73661B (da) 1984-03-28
ZA784187B (en) 1979-09-26
RO79999A (ro) 1982-10-11
GEP19960476B (en) 1996-07-22
MD247C2 (ro) 1995-12-31
DD137588A5 (de) 1979-09-12
NZ188163A (en) 1981-10-19
FI65433C (fi) 1984-05-10
MD247B1 (ro) 1995-07-31
DK163514C (da) 1992-07-27
SI7811917A8 (en) 1997-12-31
IE47230B1 (en) 1984-01-25
EP0001024B1 (fr) 1981-01-21
YU42166B (en) 1988-06-30
IE781669L (en) 1979-02-17
DK159786D0 (da) 1986-04-09
IT1107961B (it) 1985-12-02
AU520898B2 (en) 1982-03-04
BG33887A3 (en) 1983-05-16
DK159786A (da) 1986-04-09
NO156168C (no) 1987-08-19
HRP931395B1 (en) 1996-04-30
ES472381A1 (es) 1979-03-16
NO156168B (no) 1987-04-27
IT7850648A0 (it) 1978-08-08
DE2860358D1 (en) 1981-03-12
DK163514B (da) 1992-03-09
FI65433B (fi) 1984-01-31
JPS5441890A (en) 1979-04-03
DK152213C (da) 1988-07-11
PL209080A1 (pl) 1979-06-04
MX155976A (es) 1988-06-06
AT366049B (de) 1982-03-10
AU3896578A (en) 1980-02-21
PT68431A (fr) 1978-09-01

Similar Documents

Publication Publication Date Title
CS207646B2 (en) Method of making the crystallic hydrated form of the sodium salt of the oximine derivative of the 7-aminothiazolylacetamidocephalosporan acid
KR100245938B1 (ko) 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 결정성 수화물 및 이들의 제조방법
KR0180798B1 (ko) 결정성 페니실린 유도체, 그의 제법 및 용도
CH634578A5 (de) Verfahren zur herstellung von neuen cephalosporinderivaten.
NL192266C (nl) Werkwijze voor het bereiden van een kristallijn cefepime-dihydrochloride alsmede het kristallijne dihydrochloride en mengsels die het bevatten.
RU2125571C1 (ru) СОЛЬ 7-([1α,5α,6α]-6-АМИНО-3-АЗАБИЦИКЛО [3.1.0] ГЕКС-3-ИЛ)-6-ФТОР-1-(2,4-ДИФТОРФЕНИЛ)-1,4- ДИГИДРО-4-ОКСО-1,8-НАФТИРИДИН-3-КАРБОНОВОЙ И МЕТАНСУЛЬФОНОВОЙ КИСЛОТ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
JPH01313482A (ja) ３−アリル及び３−ブテニル−３−セフェムの製造
JPH045038B2 (da)
FI65069C (fi) Foerfarande foer framstaellning av kristallvattenfri ny-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat
EP0280157B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
SU845789A3 (ru) Способ получени -7- -(4-окси-6-метил-НиКОТиНАМидО)- -(4-ОКСифЕНил)АцЕТАМидО -3- (1-МЕТилТЕТРАзОл-5-ил)ТиОМЕТил-3-цЕфЕМ-4-КАРбО-НОВОй КиСлОТы
DD261163A5 (de) Verfahren zur reinigung von cephalosporin-antibiotika
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
JPH0324086A (ja) 結晶質セフェム酸付加塩およびそれらの製法
JPH0317840B2 (da)
CZ21598A3 (cs) Způsob přípravy izolované krystalické formy 3/2 hydrátu 7-[(7-(S)-amino-5-azaspirol[2,4]heptal-5-yl]-8-chlor-6-fluor-1-[(1R,2S)-2-fluorcyklopropyl]-4-oxo-1,4-dihydrochinolin-3-karboxylové kyseliny
JP2575590B2 (ja) トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
DD204257A5 (de) Verfahren zur herstellung von cephalosporinen, die in position 3 substituiert sind
CH521374A (de) Verfahren zur Herstellung von 7-(a-(4-Pyridylthio)-acetamido)- 3-cephem-4-carbonsäuren
KR960011778B1 (ko) 신규한 결정성 세팔로스포린 유도체의 제조방법
CS195747B2 (cs) Způsob výroby krystalické bezvodé sodné soli cefamandolu
JPH06247974A (ja) セファロスポリン塩及びその製造方法
CS236000B2 (cs) Způsob přípravy nových derivátů pyridiniumthiomethylcefalosporinů
JPH06100568A (ja) セフェム化合物、その製造法およびその抗菌組成物
DD137588C4 (de) Verfahren zur Herstellung einer Kristailform von 7-Amino-thiazolyl-azetamidozephalosporansäuresalzen